Copyright
        ©The Author(s) 2020.
    
    
        World J Gastrointest Oncol. May 15, 2020; 12(5): 549-558
Published online May 15, 2020. doi: 10.4251/wjgo.v12.i5.549
Published online May 15, 2020. doi: 10.4251/wjgo.v12.i5.549
		Figure 1 Flowchart of the study.
		
			 HIPEC: Hyperthermic intraperitoneal chemotherapy; CRCPM: Colorectal cancer with peritoneal metastases.
		
	
		Figure 2 Overall survival of the whole cohort according to occurrence of neutropenia, P = 0.
		
			07.
		
	
		Figure 3 Disease-free survival of the whole cohort according to occurrence of neutropenia, P = 0.
		
			02.
		
	
- Citation: Cashin PH, Ghanipour L, Enblad M, Morris DL. Neutropenia in colorectal cancer treated with oxaliplatin-based hyperthermic intraperitoneal chemotherapy: An observational cohort study. World J Gastrointest Oncol 2020; 12(5): 549-558
 - URL: https://www.wjgnet.com/1948-5204/full/v12/i5/549.htm
 - DOI: https://dx.doi.org/10.4251/wjgo.v12.i5.549
 
